GENEration Hope
DiagnosisPhelan-McDermidGene TherapyAI + Medicine

Dr. Curtis Rogers on Phelan-McDermid: Diagnosis, Newborn Screening, AI & Gene Therapy Delivery

Dr. Curtis Rogers

Senior Clinical Geneticist, Greenwood Genetic Center

About this conversation

Dr. Curtis Rogers is a Senior Clinical Geneticist at the Greenwood Genetic Center and a long-time leader in the Phelan-McDermid syndrome (PMS) community. In this wide-ranging conversation recorded at the 2024 Phelan-McDermid community conference, we talk about: • What inspired Dr.

Rogers to pursue medicine and genetics • How Phelan-McDermid syndrome was first recognized • How families built a community even before the internet • How genetic testing evolved from early chromosome studies to today’s sequencing • Why access, wait times, and insurance can slow diagnosis • The promise—and ethical complexity—of newborn screening • Where AI is beginning to help in clinical genetics • Why delivering genetic medicines to the brain is one of the biggest real-world challenges GENEration Hope shares stories and science from the rare disease community—focused on what’s changing now, and what’s coming next. ▶️ Subscribe for more interviews: @GENErationHope_1 🌐 Learn more: generationhope.co #PhelanMcDermid #SHANK3 #RareDisease #Genetics #GeneTherapy

Key topics

  • genetic diagnosis
  • newborn screening
  • AI
  • gene therapy delivery

Transcript

Download the full transcript as a text file for accessibility, quoting, and reference.

Download transcript

Related explainers and articles

Related interviews